Assessment of Physicochemical Properties of Rituximab Related to Its Immunomodulatory Activity

Rituximab is a chimeric monoclonal antibody employed for the treatment of CD20-positive B-cell non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis and microscopic polyangiitis. It binds specifically to the CD20 antigen expressed on pre-B...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunol Res
Main Authors: Miranda-Hernández, Mariana P., López-Morales, Carlos A., Ramírez-Ibáñez, Nancy D., Piña-Lara, Nelly, Pérez, Nestor O., Molina-Pérez, Aarón, Revilla-Beltri, Jorge, Flores-Ortiz, Luis F., Medina-Rivero, Emilio
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4418000/
https://ncbi.nlm.nih.gov/pubmed/25973441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/910763
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados